There are 2789 resources available
1154P - Circulating tumor DNA analysis integrating tumor clonality detects minimal residual disease in resectable non-small cell lung cancer
Presenter: Rong Yin
Session: ePoster Display
1114P - Comparative study of combined large cell neuroendocrine carcinoma and combined small cell carcinoma in resected high-grade neuroendocrine tumors of the lung
Presenter: Yanan Wang
Session: ePoster Display
1275P - Mutational landscape of non-small cell lung carcinoma in patients with different types of premalignant bronchial lesions
Presenter: Tatiana Gerashchenko
Session: ePoster Display
1157P - Diagnostic therapeutic pathway (DTP) of early stage non-small cell lung cancer (eNSCLC): A real-world focus on EGFR status detection in resected patients (pts)
Presenter: Giulia Pasello
Session: ePoster Display
1158P - Real-world adjuvant treatment patterns and survival outcomes among early NSCLC US patients
Presenter: Jay Lee
Session: ePoster Display
1117P - Mutational landscape of large cell neuroendocrine lung carcinoma: Molecular characterization using next generation sequencing
Presenter: Maria San Roman-Gil
Session: ePoster Display
1161P - Can 18F-FDG-PET/CT predict PD-L1 expression in resected non-small cell lung cancer (NSCLC)?
Presenter: Daniel Hughes
Session: ePoster Display
1162P - Clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma patients (CRISP): First real-world evidence of NSCLC stage II and III in Germany - AIO-TRK-0315
Presenter: Andreas Gröschel
Session: ePoster Display
1163P - Combined large cell neuroendocrine carcinoma: Clinical characteristics, prognosis and postoperative management
Presenter: Baohui Han
Session: ePoster Display
1164P - Whole-course management of surgical NSCLC patients based on ctDNA detection: Neo-adjuvant treatment efficacy prediction and postoperative recurrence monitoring
Presenter: Dongsheng Yue
Session: ePoster Display